|
Volumn 22, Issue 4, 2008, Pages 392-393
|
Gabapentin for breakthrough pain due to bone metastases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GABAPENTIN;
MORPHINE;
OPIATE;
ADJUVANT THERAPY;
ADVANCED CANCER;
ANALGESIA;
BODY MOVEMENT;
BONE METASTASIS;
BONE PAIN;
CANCER PAIN;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
LETTER;
LOW DRUG DOSE;
MONOTHERAPY;
NAUSEA AND VOMITING;
NEUROPATHIC PAIN;
NONHUMAN;
OUTCOME ASSESSMENT;
PAIN ASSESSMENT;
RATING SCALE;
REST;
SOMNOLENCE;
TREATMENT DURATION;
VOMITING;
AMINES;
ANALGESICS;
BONE NEOPLASMS;
CYCLOHEXANECARBOXYLIC ACIDS;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
PAIN;
PAIN MEASUREMENT;
TREATMENT OUTCOME;
|
EID: 46049112684
PISSN: 02692163
EISSN: None
Source Type: Journal
DOI: 10.1177/0269216308089304 Document Type: Letter |
Times cited : (30)
|
References (6)
|